Bio-Techne (TECH) Misses Q3 EPS by 8c
Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $0.81, $0.08 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $131 million versus the consensus estimate of $122.65 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.